Menu

Star on GitHub · 3.3k

CVE-2023-26979

3.1 · LOW

Bluetens Electrostimulation Device BluetensQ device app version 4.3.15 is vulnerable to Man-in-the-middle attacks in the BLE channel.

Published Aug 3, 2023CWE-924EPSS 0.20%

Overview

CVE-2023-26979 is a low-severity vulnerability. It was published on August 3, 2023 and has a CVSS 3.1 base score of 3.1 (LOW).

This vulnerability has a CVSS 3.1 base score of 3.1, rated LOW. It requires local or adjacent network access to exploit. No authentication or special privileges are required for exploitation.

Technical description

Bluetens Electrostimulation Device BluetensQ device app version 4.3.15 is vulnerable to Man-in-the-middle attacks in the BLE channel. It allows attackers to decrease or increase the intensity of the stimulator by hijacking the BLE communication.

Remediation

Check the references section for vendor advisories, patches, and mitigation guidance. If immediate patching is not possible, review the CVSS vector to understand the attack surface and apply compensating controls such as network segmentation or access restrictions.

Frequently asked questions

What is CVE-2023-26979?

CVE-2023-26979 is a low-severity vulnerability. It was published on August 3, 2023 and has a CVSS 3.1 base score of 3.1 (LOW).

How severe is CVE-2023-26979?

This vulnerability has a CVSS 3.1 base score of 3.1, rated LOW. It requires local or adjacent network access to exploit. No authentication or special privileges are required for exploitation.

How do I fix or remediate CVE-2023-26979?

Check the references section for vendor advisories, patches, and mitigation guidance. If immediate patching is not possible, review the CVSS vector to understand the attack surface and apply compensating controls such as network segmentation or access restrictions.

How can CyberStrike help with CVE-2023-26979?

CyberStrike is an open-source, AI-augmented pentesting engine. Rather than flag a version number, it tests whether an issue like CVE-2023-26979 is actually reachable in your own applications and APIs, then verifies each finding before reporting it. That tells you if the weakness is a real, exploitable risk in your environment or a false positive you can safely deprioritize.

Related LOW CVEs from 2023

View all
LiveWatch live →